Clinical trial

Brown Adipose Tissue Activity in Response to Semaglutide Administered to Obese Subjects.

NCT05419726

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2023-02-01

PhaseN/A

Study timeline

Study start (actual)2023-02-01Date precision: day

Registry last updated2025-05-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Obesityunresolved

Interventions

Semaglutide Injectable Product (not provided by the study)DRUG

Sponsors & collaborators

University of California, Los Angeleslead sponsor

Mapped research locations

Los AngelesCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05419726 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.